Prosecution Insights
Last updated: May 29, 2026

Examiner: KOO, BENJAMIN K

Tech Center 3700 • Art Units: 3763 3783

This examiner grants 57% of resolved cases

Performance Statistics

57.0%
Allow Rate
-13.0% vs TC avg
248
Total Applications
+49.7%
Interview Lift
1201
Avg Prosecution Days
Based on 207 resolved cases, 2023–2026

Rejection Statute Breakdown

0.3%
§101 Eligibility
9.9%
§102 Novelty
83.1%
§103 Obviousness
4.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19273952 ABLATION SYSTEMS, DEVICES AND METHODS FOR THE TREATMENT OF TISSUE Non-Final OA Fractyl Health, Inc.
17694800 Catheter Non-Final OA TERUMO KABUSHIKI KAISHA
18114049 Dual Cavity Hemostasis Valve Hub for Large Bore Introducer Sheaths Non-Final OA Boston Scientific Scimed Inc.
17671278 FLUID TITRATION SYSTEM Non-Final OA MASIMO CORPORATION
18113347 Catheter Adapter with Stabilization Feature Non-Final OA Becton, Dickinson and Company
17961979 Plastic Stopper Final Rejection Becton, Dickinson and Company
17860525 System and Method for Detecting Priming of a Fluid Path of a Drug Delivery Device Non-Final OA Becton, Dickinson and Company
17714820 VASCULAR ACCESS DEVICE HAVING A PHOSPHORESCENT FEATURE Final Rejection Becton, Dickinson and Company
17632145 BUCCAL ADMINISTRATION OF AEROSOL Non-Final OA STAMFORD DEVICES LIMITED
17355884 COMPACT VALVE Non-Final OA JOHNSON & JOHNSON SURGICAL VISION, INC.
18174624 ASPIRATION CATHETER INCLUDING A LUBRICIOUS INNER LINER AND FLEXIBLE DISTAL TIP Non-Final OA Deepin Technologies, LLC
17494752 TRANSCERVICAL ACCESS SYSTEMS FOR INTRAUTERINE FLUID EXCHANGE, SUCH AS PLACEMENT OF HYDROGELS FORMED IN SITU Non-Final OA Pramand LLC
18035617 MINI-INVASIVE SURGICAL NOZZLE, ESPECIALLY FOR INVASIVE SURGERY PURPOSES Non-Final OA SKALA-MEDICA S.R.O.
17837273 Medication Delivery System and Method Non-Final OA Sadleir Laboratories Pty Ltd
17748586 MEDICAL INSTRUMENT SUPPORT DEVICE Non-Final OA VASCULAR BARCELONA DEVICES, S.L.
17727185 ADHESIVE PATCH Final Rejection UNOMEDICAL A/S

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month